Outcomes and Safety of PD-1 Blockades Plus Anlotinib Regimen in Previously-Treated Metastatic Esophageal Squamous Cell Carcinoma: A Retrospective, Exploratory Study. - Zhang S; Su C; Shen ZB; Huo J; Yang JP (Drug design, development and therapy, 2026)